Explanatory note
This note is not part of the regulations, but is intended to indicate their general effect.
These regulations, which come into force on 3 November 2014, prescribe fees and levies payable to the Psychoactive Substances Regulatory Authority (the Authority) under the Psychoactive Substances Act 2013 (the Act).
Regulation 4 and Schedule 1 prescribe the fees payable for an application for a licence made under section 13 of the Act and for an application for approval of a psychoactive product made under section 33 of the Act.
Regulation 5 imposes an annual levy on persons granted a licence under the Act and on the person who applied for an approval of a psychoactive product that has been granted by the Authority. The rates of the annual levy payable by different classes of persons are set out in Schedule 2.
Regulation 6 authorises the Authority to waive or refund (in whole or in part) any fee or levy otherwise payable under these regulations.
Regulation 7 provides that the fees and levies payable under these regulations are inclusive of goods and services tax.
Regulatory impact statement
The Ministry of Health produced a regulatory impact statement on 25 June 2014 to help inform the decisions taken by the Government relating to the contents of this instrument.
A copy of this regulatory impact statement can be found at—
Issued under the authority of the Legislation Act 2012.
Date of notification in Gazette: 31 July 2014.
These regulations are administered by the Ministry of Health.